MECR Knockout HEK293T Cell Line

MECR Knockout HEK293T Cell Line
Cat.No.:

EDC08075

Species:

Human

Cell Name:

HEK293T

Gene:

MECR

Gene ID:

51102

Size:

1×10⁶cells

MECR Knockout HEK293T Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
Cat.No. EDC08075
Product Name MECR Knockout HEK293T Cell Line
Species Human
Cell Line HEK293T
Cellosaurus ID CVCL_0063
Gene ID
Cell Line Synonyms Hek293T, HEK-293T, HEK 293T, HEK-293-T, HEK 293 T, 293-T, 293 T, 293T, Human Embryonic Kidney 293T, 293tsA1609neo
Gene MECR
Summary
The protein encoded by this gene is an oxidoreductase that catalyzes the last step in mitochondrial fatty acid synthesis. Defects in this gene are a cause of childhood-onset dystonia and optic atrophy. [provided by RefSeq, Mar 2017]
Associated Diseases Non-tumor
Digestion Time 30 sec~1 min
Morphology Adherent
Passage Ratio 1:5
Complete Culture Medium DMEM+10% FBS+1% NEAA+1% GlutaMax
Freezing Medium 95% complete culture medium + 5% DMSO
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
LociSTR Info (Sample Cell)
Sample Cell Line: HEK293T
STR Info (Cell bank)
Cell Line: HEK293T
Allele1Allele2Allele3Allele1Allele2Allele3
Amelogenin X X
CSF1PO 11 12 11 12
D2S1338 19 19
D3S1358 15 16 17 15 16 17
D5S818 8 9 8 9
D7S820 11 11
D8S1179 11 12 14 12 14
D13S317 12 14 12 14
D16S539 9 13 9 13
D18S51 17 18 17 18
D19S433 18 18
D21S11 28 30.2 28 30.2
FGA 23 23
Penta D 9 10 9 10
Penta E 7 15 7 15
TH01 7 9.3 7 9.3
TPOX 11 11
vWA 16 19 16 19
D6S1043 11
D12S391 19 21 19 21
D2S441 11 15 11 15
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.

FAQ

The choice depends on whether you are studying MECR (mitochondrial trans-2-enoyl-CoA reductase)'s role as the terminal enzyme of mitochondrial fatty acid synthesis II (mtFASII) or modeling MEPAN (MECR-associated neurodegeneration) syndrome. The Knockout line is the standard tool for asking whether MECR is required for these processes — MECR catalyzes the NADPH-dependent reduction of mitochondrial trans-2-enoyl-ACP intermediates during de novo fatty acid synthesis within mitochondria, distinct from the cytosolic FAS pathway. mtFASII generates octanoyl-ACP, the substrate for lipoic acid synthesis (essential for PDC, KGDH, BCKDH function). Overexpression is useful for studying MECR in heterologous expression contexts. For mitochondrial metabolism research, the EDITGENE MECR Knockout in HEK293T is highly informative — HEK293T's very high transfection efficiency supports systematic structure-function studies. MECR biallelic loss-of-function mutations cause MEPAN (autosomal recessive childhood-onset dystonia with optic atrophy and basal ganglia abnormalities, with bilateral basal ganglia degeneration on MRI) — disease variant rescue enables genotype-function studies. Rescue with wild-type or catalytically-dead MECR enables comprehensive structure-function studies. The knockout is valuable for studying lipoic acid biosynthesis, PDC/KGDH lipoylation, and emerging mtFASII-related therapeutic strategies.
Primary applications: • Lipoic acid biosynthesis: lipoylation status of PDC (PDHA1), KGDH (DLST), BCKDH (DBT), and GCS (GCSH) E2/H components by anti-lipoyl Western blot — mtFASII loss reduces lipoylation. • Mitochondrial bioenergetics: Seahorse OCR/ECAR analysis given mtFASII's contribution to mitochondrial complex function via lipoylation. • MEPAN modeling: rescue with patient-derived MECR mutations for genotype-function correlation studies of MECR-associated neurodegeneration. • mtFASII pathway analysis: ACP (mt-ACP) acyl chain composition by mass spectrometry to characterize mtFASII flux in the absence of MECR. EDITGENE recommends this model for researchers investigating mitochondrial fatty acid synthesis, lipoic acid biology, MEPAN disease mechanisms, and mtFASII-related metabolic disease.
Yes. MECR rescue experiments require attention to mitochondrial targeting: • Construct design: use a codon-modified MECR sequence with a small C-terminal tag (FLAG, HA). MECR has N-terminal mitochondrial targeting sequence cleaved upon import — N-terminal tags must not disrupt processing. • Mitochondrial localization validation: confirm mitochondrial matrix localization by appropriate compartment markers. • Catalytically-dead rescue: NADPH-binding or substrate-binding pocket mutations abolish enoyl-CoA reductase activity and serve as the standard specificity control. • MEPAN mutation rescue: patient-derived MECR mutations enable disease genotype-function studies. • Functional readout: rescue should restore PDC/KGDH/BCKDH lipoylation status (anti-lipoyl Western blot) and mitochondrial respiration as functional outputs of restored mtFASII. HEK293T transduces with very high efficiency and supports systematic structure-function rescue experiments.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.

Required Accessories

Related Products

Flash CRISPR Knockout Kit(Universal Version)Flash CRISPR Knockout Kit(Universal Version)
Flash-Pro CRISPR KO Kit (For Organoids / Stem Cells)Flash-Pro CRISPR KO Kit (For Organoids / Stem Cells)

Related Services

Knockout Cell LineKnockout Cell Line
Contact Us
*
*
*
*
How did you hear about us: